Phase II study of pyrazofurin in advanced colorectal carcinoma

Cancer Treat Rep. 1977 May-Jun;61(3):491-3.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / immunology
  • Amides
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / immunology
  • Digestive System / drug effects
  • Humans
  • Leukopenia / chemically induced
  • Lymphocytes / immunology
  • Prognosis
  • Pyrazoles
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / immunology
  • Ribonucleosides / administration & dosage
  • Ribonucleosides / adverse effects
  • Ribonucleosides / therapeutic use*
  • Ribose

Substances

  • Amides
  • Antibiotics, Antineoplastic
  • Pyrazoles
  • Ribonucleosides
  • pyrazofurin
  • Ribose